Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

October 23, 2024 news

$Adial Pharmaceuticals (ADIL.US)$ Adial Pharmaceuticals to Present at the 2024 ThinkEquity Conference

GLEN ALLEN, Va., Oct. 23, 2024 — Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced that it will be participating in The ThinkEquity Conference on October 30, 2024, at the Mandarin Oriental Hotel in New York. The ThinkEquity Conference gathers institutional investors, corporate clients, and other industry professionals to highlight groundbreaking innovations and financial strategies.

Cary Claiborne, Chief Executive Officer of Adial, will be presenting at 8:30 a.m. ET on October 30th. Management will also be holding one-on-one investor meetings throughout the day. Interested investors can register to attend and schedule on-on-one meetings here.

The presentation will also be live-streamed at the following link: https://wsw.com/webcast/tep25/adil/1651104.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
Translate
Report
1560 Views
Comment
Sign in to post a comment
    birds of a feather, we should stick together.
    7Followers
    25Following
    81Visitors
    Follow